HXN6005

DRUG2 trials

Sponsors

Helixon Biotechnology (Suzhou) Co., Ltd

Conditions

Atopic Dermatitis (AD)Health Adult SubjectsHealthy Volunteers (HV)

Phase 1

Phase I Study of HXN6005 in Adult Healthy Participants

RecruitingNCT07449741

Helixon Biotechnology (Suzhou) Co., LtdHealthy Volunteers (HV)

Start: 2026-04-27End: 2027-03-13Target: 32Updated: 2026-04-24

Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis

Not yet recruitingNCT07782476

Helixon Biotechnology (Suzhou) Co., LtdAtopic Dermatitis (AD), Health Adult Subjects

Start: 2026-09-01End: 2028-01-01Target: 67Updated: 2026-08-24